US Patent Issued to MEMORIAL SLOAN KETTERING CANCER CENTER on Jan. 20 for "WT1 HLA class II-binding peptides and compositions and methods comprising same" (Maryland, New York, Florida Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,849, issued on Jan. 20, was assigned to MEMORIAL SLOAN KETTERING CANCER CENTER (New York).

"WT1 HLA class II-binding peptides and compositions and methods comprising same" was invented by David Scheinberg (New York), Javier Pinilla-Ibarz (Tampa, Fla.) and Rena May (Baltimore).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention provides WT1 peptides and methods of treating, reducing the incidence of, and inducing immune responses against a WT1-expressing cancer, comprising same."

The patent was filed on May 13, 2022, under Application No. 17/744,465.

*For further information, including images, charts and tables, please visit: http://patft....